Yubo International Valuation

YBGJ Stock  USD 0.04  0.0003  0.86%   
Yubo International seems to be fairly valued based on Macroaxis valuation methodology. Our model calculates the value of Yubo International from examining the company fundamentals such as Return On Asset of -0.26, shares outstanding of 119.82 M, and Operating Margin of (4.59) % as well as analyzing its technical indicators and probability of bankruptcy.
Fairly Valued
Today
0.04
Please note that Yubo International's price fluctuation is out of control at this time. Calculation of the real value of Yubo International is based on 3 months time horizon. Increasing Yubo International's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Yubo International's intrinsic value may or may not be the same as its current market price of 0.04, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  0.035 Real  0.0336 Hype  0.04
The intrinsic value of Yubo International's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Yubo International's stock price.
0.03
Real Value
19.01
Upside
Estimating the potential upside or downside of Yubo International Biotech helps investors to forecast how Yubo pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Yubo International more accurately as focusing exclusively on Yubo International's fundamentals will not take into account other important factors:
Hype
Prediction
LowEstimatedHigh
0.000.0419.02
Details

Yubo International Total Value Analysis

Yubo International Biotech is at this time forecasted to have valuation of 14.08 M with market capitalization of 10.54 M, debt of 2.4 M, and cash on hands of 36.58 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Yubo International fundamentals before making equity appraisal based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
14.08 M
10.54 M
2.4 M
36.58 K

Yubo International Investor Information

About 95.0% of the company outstanding shares are owned by insiders. The company recorded a loss per share of 0.01. Yubo International had not issued any dividends in recent years. The entity had 1:100 split on the 5th of March 2007. Yubo International Biotech is not in a good financial situation at this time. It has a very high probability of going through financial hardship in February.

Yubo International Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Yubo International has an asset utilization ratio of 2.7128254E7 percent. This denotes that the Company is making $271283.0 for each dollar of assets. An increasing asset utilization means that Yubo International Biotech is more efficient with each dollar of assets it utilizes for everyday operations.

Yubo International Ownership Allocation

Yubo International Biotech retains a total of 119.82 Million outstanding shares. Yubo International maintains majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 95.45 (%) of Yubo International outstanding shares that are owned by insiders attests that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company shows, if the real value of the company is less than the current market value, you may not be able to make money on it.

Yubo International Profitability Analysis

The company reported the previous year's revenue of 1.24 B. Net Loss for the year was (1.54 B) with profit before overhead, payroll, taxes, and interest of 820.65 K.

About Yubo International Valuation

An absolute valuation paradigm, as applied to Yubo Pink Sheet, attempts to find the value of Yubo International based on its fundamental and basic technical indicators. By analyzing Yubo International's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Yubo International's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Yubo International. We calculate exposure to Yubo International's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Yubo International's related companies.
Yubo International Biotech Limited, thorough its subsidiaries, focuses on the research and development, and application of endometrial stem cells. It offers healthcare products for respiratory system, skincare products, hair care products, healthy beverages, and male and female personal care products and stem cell related services, including cell testing and health management consulting services under the VIVCELL brand. Yubo Intl is traded on OTC Exchange in the United States.

8 Steps to conduct Yubo International's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Yubo International's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Yubo International's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Yubo International's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Yubo International's revenue streams: Identify Yubo International's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Yubo International's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Yubo International's growth potential: Evaluate Yubo International's management, business model, and growth potential.
  • Determine Yubo International's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Yubo International's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Yubo International Growth Indicators

Investing in growth stocks can be very risky. If the company such as Yubo International does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding1.2 M
Retained Earnings-2485.43

Other Information on Investing in Yubo Pink Sheet

Yubo International financial ratios help investors to determine whether Yubo Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Yubo with respect to the benefits of owning Yubo International security.